Advertisement
BDX vs RSPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and RSPH is a StrongBuy.
BDX's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for BDX turned positive on October 09, 2026. Looking at past instances where BDX's MACD turned positive, the stock continued to rise in 26 of 47 cases over the following month. The odds of a continued upward trend are 55%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on BDX as a result. In 55 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
BDX moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BDX crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +7.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDX advanced for three days, in 134 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 114 of 218 cases where BDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
BDX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 4 (best 1 - 100 worst), indicating outstanding price growth. BDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.364) is normal, around the industry mean (4.964). P/E Ratio (63.819) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (1.107) is also within normal values, averaging (4.143). BDX has a moderately high Dividend Yield (0.020) as compared to the industry average of (0.005). P/S Ratio (2.290) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
RSPH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for RSPH turned positive on October 12, 2026. Looking at past instances where RSPH's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on RSPH as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +2.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where RSPH advanced for three days, in 254 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 235 of 304 cases where RSPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Bearish Trend Analysis
The 10-day RSI Indicator for RSPH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
RSPH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
BDX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | |
SMR RATING 1..100 | 85 | |
PRICE GROWTH RATING 1..100 | 4 | |
P/E GROWTH RATING 1..100 | 5 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BDX | RSPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 67% | 1 day ago 80% |
| Stochastic ODDS (%) | 1 day ago 54% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 54% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 55% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 50% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 82% |
| Advances ODDS (%) | 7 days ago 46% | 3 days ago 84% |
| Declines ODDS (%) | 16 days ago 42% | 24 days ago 77% |
| BollingerBands ODDS (%) | 1 day ago 49% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 52% | 1 day ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 2 FA rating(s) are green while .
- BDX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 6 TA indicator(s) are bullish.
- BDX’s TA Score: 6 bullish, 4 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +2.55% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.
Reported Earning Dates
BDX is expected to report earnings on Feb 04, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+2.07% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
RSPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, RSPH has been closely correlated with BDX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RSPH jumps, then BDX could also see price increases.
| Ticker / NAME | Correlation To RSPH | 1D Price Change % | ||
|---|---|---|---|---|
| RSPH | 100% | +0.07% | ||
| BDX - RSPH | 67% Closely correlated | +0.90% | ||
| SYK - RSPH | 64% Loosely correlated | -1.70% | ||
| STE - RSPH | 63% Loosely correlated | -0.33% | ||
| MDT - RSPH | 62% Loosely correlated | +0.02% | ||
| RMD - RSPH | 61% Loosely correlated | +1.89% | ||
More | ||||